CEFAZOLIN SODIUM (CEFAZOLIN SODIUM) — FDA Approval NDA211413 (HQ SPCLT PHARMA)
CEFAZOLIN SODIUM (CEFAZOLIN SODIUM) — FDA Approval NDA211413 (HQ SPCLT PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CEFAZOLIN SODIUM; Active ingredients: CEFAZOLIN SODIUM; Application number: NDA211413.
| Brand name | CEFAZOLIN SODIUM |
|---|---|
| Active ingredients | CEFAZOLIN SODIUM |
| Application number | NDA211413 |
| Sponsor | HQ SPCLT PHARMA |
| Dosage form | POWDER |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20230508 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →